Mount Tam Biotechnologies has entered into a multi-year research collaboration with the Buck Institute for Research on Aging. This collaboration greatly enhances the capabilities of Mount Tam, bringing together our expertise in medicinal chemistry, pre-clinical and clinical development, and commercialization with the superlative science being done at the Buck Institute. In particular, Mount Tam and the Buck Institute are combining their expertise in understanding the mTOR pathway, enhancing knowledge and allowing Mount Tam to become a leader in the development of novel mTOR modulators.
The Buck Institute is the first and foremost independent nonprofit research organization in the United States devoted to Geroscience – an area of science focused on the connection between normal aging and chronic disease. The Buck is dedicated to extending “healthspan,” the healthy years of human life, and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging. Buck scientists strive to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer’s and Parkinson’s, cancer, cardiovascular disease, osteoporosis, autoimmune diseases, macular degeneration, diabetes, and stroke. In their collaborative research, they are supported by the most recent developments in genomics, stem cell technologies, proteomics, and bioinformatics.
If you are interested in exploring opportunities to collaborate with Mount Tam Biotechnologies, please contact our Chief Financial Officer, Jim Stapleton at firstname.lastname@example.org